<?xml version="1.0" encoding="UTF-8"?>
<p id="Par11">In the cycle of infection for most virus, the first step is to attach to the surface and recognize cell surface receptor of the host cell for invasion.
 <sup>
  <xref ref-type="bibr" rid="CR15">15</xref>,
  <xref ref-type="bibr" rid="CR16">16</xref>
 </sup> With similar external subdomain of receptor-binding domain (RBD), 2019-nCoV spike share same host-cell receptor—angiotensin-converting enzyme II (ACE2)—with SARS-CoV spike, but in a higher affinity than SARS-CoV spike.
 <sup>
  <xref ref-type="bibr" rid="CR17">17</xref>–
  <xref ref-type="bibr" rid="CR21">21</xref>
 </sup> In another word, cells expressing cell surface receptor ACE2 are susceptible to 2019-nCoV, similar to SARS-CoV. ACE2 was found expressed in lungs, esophagus, ileum, colon, cholangio of liver, and bladder.
 <sup>
  <xref ref-type="bibr" rid="CR22">22</xref>–
  <xref ref-type="bibr" rid="CR25">25</xref>
 </sup> Consistently, bronchoalveolar-lavage fluid,
 <sup>
  <xref ref-type="bibr" rid="CR2">2</xref>
 </sup> nasopharyngeal swabs,
 <sup>
  <xref ref-type="bibr" rid="CR26">26</xref>
 </sup> stool,
 <sup>
  <xref ref-type="bibr" rid="CR27">27</xref>,
  <xref ref-type="bibr" rid="CR28">28</xref>
 </sup> and blood
 <sup>
  <xref ref-type="bibr" rid="CR17">17</xref>
 </sup> of COVID-19 patients were RT-PCR-positive for 2019-nCoV. Several studies have shown that salivary gland and tongue express ACE2 receptor, suggesting oral cavity as host for 2019-nCoV to invade.
</p>
